Nothing Special   »   [go: up one dir, main page]

BRPI1011888A2 - processo para preparar um composto, e, composição. - Google Patents

processo para preparar um composto, e, composição.

Info

Publication number
BRPI1011888A2
BRPI1011888A2 BRPI1011888A BRPI1011888A BRPI1011888A2 BR PI1011888 A2 BRPI1011888 A2 BR PI1011888A2 BR PI1011888 A BRPI1011888 A BR PI1011888A BR PI1011888 A BRPI1011888 A BR PI1011888A BR PI1011888 A2 BRPI1011888 A2 BR PI1011888A2
Authority
BR
Brazil
Prior art keywords
preparing
compound
composition
Prior art date
Application number
BRPI1011888A
Other languages
English (en)
Inventor
Karl-Heinz Giselbrecht
Michael Wolberg
Ulfried Felfer
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of BRPI1011888A2 publication Critical patent/BRPI1011888A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BRPI1011888A 2009-07-02 2010-07-01 processo para preparar um composto, e, composição. BRPI1011888A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27007309P 2009-07-02 2009-07-02
PCT/US2010/040792 WO2011002999A1 (en) 2009-07-02 2010-07-01 Synthesis of n4- (2, 2-dimethyl-4- [ (dihydrogen phosphonoxy ] -3-oxo-5-pyrido [1, 4] oxazin-6-yl)-5-fluoro-n2- (3, 4, 5,-trimethoxyphenyl) -2, 4- pyrimidinediamine disodium salt

Publications (1)

Publication Number Publication Date
BRPI1011888A2 true BRPI1011888A2 (pt) 2016-04-12

Family

ID=42937685

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1011888A BRPI1011888A2 (pt) 2009-07-02 2010-07-01 processo para preparar um composto, e, composição.

Country Status (22)

Country Link
US (3) US8299242B2 (pt)
EP (1) EP2448950B1 (pt)
JP (1) JP5739882B2 (pt)
CN (1) CN102482305B (pt)
AU (1) AU2010266213B2 (pt)
BR (1) BRPI1011888A2 (pt)
CA (1) CA2766801C (pt)
CY (1) CY1117489T1 (pt)
DK (1) DK2448950T3 (pt)
EA (1) EA021657B1 (pt)
ES (1) ES2565985T3 (pt)
HK (1) HK1169996A1 (pt)
HR (1) HRP20160319T1 (pt)
HU (1) HUE027212T2 (pt)
ME (1) ME02388B (pt)
PL (1) PL2448950T3 (pt)
RS (1) RS54679B1 (pt)
SG (1) SG176799A1 (pt)
SI (1) SI2448950T1 (pt)
SM (1) SMT201600084B (pt)
UA (1) UA108077C2 (pt)
WO (1) WO2011002999A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8318720B2 (en) 2006-07-20 2012-11-27 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as Fab I inhibitors
UA108077C2 (xx) 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну
WO2011106248A2 (en) * 2010-02-24 2011-09-01 Auspex Pharmaceuticals, Inc. Trimethoxyphenyl inhibitors of tyrosine kinase
AU2012288632B2 (en) 2011-07-28 2017-08-17 Rigel Pharmaceuticals, Inc. New (trimethoxyphenylamino)pyrimidinyl formulations
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
US8426450B1 (en) * 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
PT2861608T (pt) 2012-06-19 2019-06-28 Debiopharm Int Sa Derivados pró-fármacos de (e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-oxo-5,6,7,8-tetra-hidro-1,8-naftiridin-3-il)acrilamida
CN102746337B (zh) * 2012-06-21 2014-12-17 成都苑东药业有限公司 一种2,4-嘧啶二胺类化合物及其制备方法
WO2014022728A1 (en) 2012-08-02 2014-02-06 Endo Pharmaceuticals, Inc Substituted 5 - (quinazolin - 2 - yl) pyrimidin- 2 -amine derivatives useful as pi3k/mtor inhibitors for the treatment of cancer
EP3083648B1 (en) * 2013-12-20 2018-09-12 Rigel Pharmaceuticals, Inc. Pharmaceutical process and intermediates
SI3419628T1 (sl) 2016-02-26 2021-03-31 Debiopharm International Sa Zdravilo za zdravljenje infekcij diabetičnega stopala
CN110087646A (zh) 2016-09-08 2019-08-02 格利康科技集团有限责任公司 单体双金属羟基柠檬酸化合物及其制备和使用方法
EP3692041A1 (en) * 2017-10-04 2020-08-12 Celgene Corporation Processes for the preparation of cis-4 [2-{(3s.4r)-3-fluorooxan-4-yl]amino)-8-(2,4,6-trichloroanilino)-9h-purin-9-yl]-1-methylcyclohexane-1-carboxamide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US303022A (en) 1884-08-05 Egg-beater
US324087A (en) 1885-08-11 Abel combs
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
AU2003221887A1 (en) 2002-04-12 2003-10-27 Tritek Technologies, Inc. Mail sorting processes and systems
ATE451104T1 (de) 2002-07-29 2009-12-15 Rigel Pharmaceuticals Inc Verfahren zur behandlung oder pruvention von autoimmunkrankheiten mit 2,4-pyrimidindiamin- verbindungen
EP1656372B1 (en) 2003-07-30 2013-04-10 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
US20060047135A1 (en) 2004-08-30 2006-03-02 Chadwick Scott T Process for preparing chloromethyl di-tert-butylphosphate
WO2006078846A1 (en) 2005-01-19 2006-07-27 Rigel Pharmaceuticals, Inc. Prodrugs of 2,4-pyrimidinediamine compounds and their uses
CN101282979B (zh) * 2005-09-13 2011-09-21 卫材R&D管理有限公司 稳定性被改善的含有磷酸氯甲酯衍生物的组合物及其制备方法
EP2078026B1 (en) * 2006-11-21 2012-01-04 Rigel Pharmaceuticals, Inc. Prodrug salts of 2, 4-pyrimidinediamine compounds and their uses
UA108077C2 (xx) 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну

Also Published As

Publication number Publication date
UA108077C2 (xx) 2015-03-25
US8299242B2 (en) 2012-10-30
EP2448950A1 (en) 2012-05-09
EA021657B1 (ru) 2015-08-31
WO2011002999A1 (en) 2011-01-06
AU2010266213B2 (en) 2015-06-18
RS54679B1 (en) 2016-08-31
DK2448950T3 (en) 2016-04-04
US20130018185A1 (en) 2013-01-17
ME02388B (me) 2016-09-20
SG176799A1 (en) 2012-01-30
CN102482305B (zh) 2016-07-13
EP2448950B1 (en) 2016-01-13
SI2448950T1 (sl) 2016-05-31
JP2012532143A (ja) 2012-12-13
PL2448950T3 (pl) 2016-06-30
US20130274499A1 (en) 2013-10-17
CY1117489T1 (el) 2017-04-26
JP5739882B2 (ja) 2015-06-24
CA2766801A1 (en) 2011-01-06
SMT201600084B (it) 2016-04-29
CN102482305A (zh) 2012-05-30
US20110003986A1 (en) 2011-01-06
EA201270114A1 (ru) 2012-05-30
HUE027212T2 (en) 2016-10-28
CA2766801C (en) 2018-03-13
AU2010266213A1 (en) 2012-02-02
US8691798B2 (en) 2014-04-08
HRP20160319T1 (hr) 2016-04-22
US8481724B2 (en) 2013-07-09
HK1169996A1 (zh) 2013-02-15
ES2565985T3 (es) 2016-04-08

Similar Documents

Publication Publication Date Title
BRPI1014547A2 (pt) composto, e, processo para preparar um composto.
BRPI1011888A2 (pt) processo para preparar um composto, e, composição.
BRPI0812054A2 (pt) Processo para preparar compostos, e, compostos.
BRPI0910910A2 (pt) processo para preparar um composto
BRPI0910911A2 (pt) processo para preparar um composto
BRPI0911898A2 (pt) processo para preparar compostos, e, composto.
BRPI0814980A2 (pt) Processo para produzir um composto, e, composto.
BRPI0909691A8 (pt) composto, método para preparar um composto, e, composição farmacêutica
BRPI0911531A2 (pt) processo para preparar iopromida, e, composto.
BRPI1012018A2 (pt) processo para preparar um composto
BR112013008008A2 (pt) composto, composição farmacêutica e processo para preparar um composto
BRPI0908252A2 (pt) Processo para preparar um composto, e, uso de um composto
BRPI1014691A2 (pt) Composto, e, processo para a preparação de um composto.
BRPI0914674A2 (pt) processo para preparação de um pó
BRPI1010933A2 (pt) processo para a preparação de um pó, e, composto
BRPI0921882A2 (pt) processo para fabricar um composto.
BRPI0909280A2 (pt) processo para preparar uretanos.
BRPI0911897A2 (pt) Processo para a preparação de compostos, e, composto
BR112012001462A2 (pt) processo para preparar metil mercaptano.
BRPI0813772A2 (pt) Composto, processo para a preparação de um composto, e, conjugado
BRPI1008987A2 (pt) processo para preparar 3,3,3-trifluoropropeno
BRPI1009816A2 (pt) "método para preparar um composto."
BRPI1016109A2 (pt) "composto, composição farmacêutica, e, processo para preparar um composto"
BRPI0914924A2 (pt) processo para preparar aminobifenilas, e, composto.
BR112012002130A2 (pt) processo para a preparação de composto,e, composto intermediário

Legal Events

Date Code Title Description
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]